Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Trial milestone for over-the-counter CBD insomnia treatment
13 Mar 2023
Published by: Next Investors
Weed Week: BOD advances Aqua Phase acquisition with stability testing
10 Mar 2023
Published by: Stockhead
Bod Science clears stability hurdle for Aqua Phase deal but PK study delayed
07 Mar 2023
Published by: Cannabiz
Secures small cash injection ahead of insomnia relief trial
06 Mar 2023
Published by: Next Investors
Rise of THC flower hits Bod CBD sales as medical revenues fall 29%
27 Feb 2023
Published by: Cannabiz
Bod strikes CBD over-the-counter deal with pharma firm Arrotex
02 Dec 2022
Published by: Cannabiz
Quick Takes Company Updates Weekend Updates Educational Articles WA gold project update & what’s next?
02 Dec 2022
Published by: Next Investors
Weed Week: Oregon pardons cannabis convictions and bulk people light up on Turkey Day
24 Nov 2022
Published by: Stockhead